Demand for Health & Safety Products at a Fever Pitch
With the number of coronavirus cases around the world continuing to climb, demand for preventive products has skyrocketed. Critical items such as hand sanitizers, masks and gloves are flying off the shelves as people continue to stock up amid the worsening scenario.
Medical, health and safety products are currently in short supply amid the pandemic that has so far claimed more than 42,000 lives and infected more than 850,000 people globally. Notably, outbreak in the United States, Italy, Spain, Germany and France has worsened over the past several days. It has rattled global stock markets on concerns over broader economic impacts.
Dr. Maria Van Kerkhove, an infectious disease epidemiologist with the World Health Organization (WHO), recently said that the world is facing a significant shortage of PPE including masks, respirators, gloves, gowns and face shields for frontline health workers.
The WHO, last month, had called on manufacturers to increase production of PPE by 40% to meet the rising global demand. The WHO is concerned that limited access to PPE supplies has left frontline workers “dangerously ill-equipped” to care for COVID-19 patients. It has urged governments to provide incentives to the industry for ramping up production of PPE and other medical supplies.
While demand for PPE first spiked in China, where the outbreak originated, it rapidly surged across the world to an unprecedented level with the spread of the lethal virus.
Looking for chemical products? Let suppliers reach out to you!
2026-05-24
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
-
Roche's Q1 Performance Increases by 10%, And Total Revenue for the Year May Slow Down Due to COVID-19, Biosimilar Competition
Recommend Reading
-
BASF to Shut Down Hydrosulfites Production in Ludwigshafen
-
Wacker Opens Biotechnology Center in Munich
-
Wacker Invests 300 Million Euros in New Semiconductor-Grade Polysilicon Production Line in Germany
-
The World's First Thousand-Ton Ionic Liquid Regenerated Fiber Project Is POut Into Production in Henan
-
Saudi Aramco Cuts Propane, Butane Prices for June
-
This week, the cyclohexanone market in Shandong, China, has been consolidating
-
Isopropyl alcohol market prices continue to fall in November in China
-
This week, the styrene market fluctuated and fell (9.1-9.5) in China
-
Premium Global Chemical Sourcing Requests (11-13May, 2026)
-
This Round of Refined Oil Retail Price Adjustment Faces Another Suspension